Skip to main content
IRS-authorized e-file provider · not the IRS

Nonprofit · EIN 99-3630868

ORPHAN THERAPEUTICS ACCELERATOR INC

Tax-exempt · ANDOVER, MA 01810

Financials

$0$364K2024
Revenue Expenses · by fiscal year end
Financials of ORPHAN THERAPEUTICS ACCELERATOR INC by year, from its e-filed returns
Year endedFormRevenueExpensesNet incomeTotal assetsLiabilitiesNet assets
December 31, 2024990-EZ$0$364,147-$364,147$0$364,147-$364,147
Financial details: 990-EZ for the year ended December 31, 2024

Revenue

Contributions, gifts and grants
$0
Program service revenue
$0
Investment income
$0
Other revenue
$0

Expenses

Grants and similar amounts paid
$0
Compensation of officers, directors and key employees
$301,780
Salaries, compensation and benefits (total)
$0
Professional fees and payments to contractors
$353,142
Other expenses
$11,005
Program services (functional)
$282,597

Balance sheet and other

Total assets, start of year
$0
Total assets, end of year
$0
Total liabilities, end of year
$364,147
Net assets, end of year
-$364,147
Gross receipts
$0

From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.

Officers, directors and key employees

As listed on the 990-EZ for the year ended December 31, 2024, highest compensation first.

NameTitleHours / weekCompensation
Donald Craig MartinChief Executive Officer / Board Director20$153,000
Elizabeth WhiteSecretary-Executive Vice President18$135,000
Deanna PorteroVice President, Partnerships and Innovation7$13,780
Nandan PadukoneTreasurer-Executive Vice President2$0
James GeraghtyBoard Director2$0
Susan KahnBoard Director2$0

Address and contacts

Address (IRS master file)
54 MORTON ST, ANDOVER, MA 01810-2014
Signed the 990-EZ
Elizabeth White, Secretary-Executive Vice President
Phone
(215) 915-8364

Mission

The specific and primary purpose of the Orphan Therapeutics Accelerator is to engage in charitable and scientific activities within the meaning of Section 501(c)(3) of the Code, including, but not limited to, the following activities: a. Providing, expanding access to, and resolving barriers to the development of therapeutic resources in the form of drugs, therapies, and other related treatments to rare diseases (collectively, the "Therapies"), so as to provide accessible treatments and potential cures to rare diseases that, otherwise, would not be available (such purposes, the "Charitable Purposes"). b. Addressing and resolving scientific barriers to development of the Therapies, which the Accelerator will accomplish via research as it acquires and shepherds the Therapies through late-stage clinical trials, so as to provide accessible treatments and potential cures for rare diseases without known and accessible treatments (such purposes, the "Scientific Purposes").

990-EZ for the year ended December 31, 2024

Program accomplishments

  • In 2024, the Orphan Therapeutics Accelerator was formed. In this initial year of operating, the organization developed a new model to bring rare disease programs that had been halted by for-profit companies through development so that these medicines could be made accessible to rare disease patients in need. We evaluated potential medicines, developed partnerships to support our model, and connected with potential funding sources.
    Expenses $282,597

What it must file and when

IRS records say it files Form 990-N (e-Postcard). Gross receipts normally $50,000 or less. Its accounting year ends in December, so each return is due on the 15th day of the 5th month after that.

Tax yearYear endedDueIRS public records
2025December 31, 2025May 15, 2026Not on file
2024December 31, 2024May 15, 2025990-EZ on file
2023December 31, 2023May 15, 2024Check at the IRS

File the 2025 990-N for ORPHAN THERAPEUTICS ACCELERATOR INC

Due May 15, 2026 · e-filed with the IRS by 990.tax, an IRS-authorized e-file provider

IRS record

EIN
99-3630868
Tax-exempt status
501(c)(3): Charitable, religious, educational or scientific organization
Foundation status
Publicly supported organization (170(b)(1)(A)(vi))
Donations deductible (Pub 78)
Public charity, 50% deduction limit
Exempt since
2024
Accounting year ends
December
Files
Form 990-N (e-Postcard)
Category (NTEE)
Medical research (H80)
Assets (IRS master file)
$1

Filing history

FormYear endedRevenueExpensesAssetsReturn
990-EZDecember 2024$0$364,147$0IRS

990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 99-3630868).

Questions about ORPHAN THERAPEUTICS ACCELERATOR INC

What is the EIN of ORPHAN THERAPEUTICS ACCELERATOR INC?
The employer identification number (EIN) of ORPHAN THERAPEUTICS ACCELERATOR INC is 99-3630868.
Is ORPHAN THERAPEUTICS ACCELERATOR INC tax-exempt?
Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 2024.
Are donations to ORPHAN THERAPEUTICS ACCELERATOR INC tax-deductible?
Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
Which annual return does ORPHAN THERAPEUTICS ACCELERATOR INC file?
Form 990-N (e-Postcard). Gross receipts normally $50,000 or less.
When is the next return of ORPHAN THERAPEUTICS ACCELERATOR INC due?
The return for tax year 2025 (the year ending December 31, 2025) is due May 15, 2026. Form 8868 extends it by six months; the 990-N cannot be extended.
When did ORPHAN THERAPEUTICS ACCELERATOR INC last file with the IRS?
The latest return in the IRS public files is the 990-EZ for the year ended December 2024.
Who are the officers and directors of ORPHAN THERAPEUTICS ACCELERATOR INC?
The 990-EZ for the year ended December 31, 2024 lists 6 people; 3 received compensation from the organization, the highest $153,000 (Donald Craig Martin, Chief Executive Officer / Board Director).
How much revenue does ORPHAN THERAPEUTICS ACCELERATOR INC have?
On its 990-EZ for the year ended December 31, 2024 it reported revenue of $0, expenses of $364,147 and total assets of $0 at year end.

Other nonprofits in ANDOVER

All nonprofits in ANDOVER · Massachusetts · Medical research